NextPlat Corp — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
NextPlat Corp completed acquisition of a profitable independent pharmacy near Pensacola, Florida for $1,485,439 in cash on October 6, 2026. The target generated ~$5.6M in annual sales (2025), operated debt-free with positive working capital, and is the sixth pharmacy in NextPlat's PharmcoRx segment. Management expects integration and margin enhancement through higher-margin contracted services (340B, long-term care).
Why this rating
Acquisition of $1.49M (~13% of $11.2M market cap) adds revenue but modest leverage; profitable target and strategic fit are positive, yet micro-cap scale limits transformational impact.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.